School of Health Science, International Medical University, 57000, Kuala Lumpur, Malaysia.
School of Pharmacy, Monash University Malaysia, 47500, Selangor, Malaysia.
Metab Brain Dis. 2021 Aug;36(6):1087-1100. doi: 10.1007/s11011-021-00737-0. Epub 2021 Apr 21.
The endosomal-lysosomal system mediates the process of protein degradation through endocytic pathway. This system consists of early endosomes, late endosomes, recycling endosomes and lysosomes. Each component in the endosomal-lysosomal system plays individual crucial role and they work concordantly to ensure protein degradation can be carried out functionally. Dysregulation in the endosomal-lysosomal system can contribute to the pathogenesis of neurodegenerative diseases such as Alzheimer's disease (AD). In AD endosomal-lysosomal abnormalities are the earliest pathological features to note and hence it is important to understand the involvement of endosomal-lysosomal dysfunction in the pathogenesis of AD. In-depth understanding of this dysfunction can allow development of new therapeutic intervention to prevent and treat AD.
内体溶酶体系统通过内吞途径介导蛋白质降解过程。该系统由早期内体、晚期内体、再循环内体和溶酶体组成。内体溶酶体系统中的每个组成部分都发挥着各自关键的作用,它们协同工作以确保蛋白质降解能够正常进行。内体溶酶体系统的失调可能导致神经退行性疾病(如阿尔茨海默病)的发病机制。在 AD 中,内体溶酶体异常是最早注意到的病理特征,因此了解内体溶酶体功能障碍在 AD 发病机制中的作用非常重要。深入了解这种功能障碍可以为预防和治疗 AD 开发新的治疗干预措施。